Patent · US Active

Transdermal rivastigmine therapeutic system

US8883198B2 · kind B2 · utility

0Cited by

12References

19Claims

0Family size

Assignee

LTS Lohmann Therapie-Systeme AG · DE

Inventors

Thomas Hille · Neuwied, DE
Lothar Deurer · Koblenz, DE

Key dates

Filing date	Feb 27, 2012
Grant date	Nov 11, 2014
Priority date	—
Expiry date	Nov 22, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to transdermal therapeutic systems (TTS) comprising a backing, a reservoir layer containing at least one pharmaceutical active ingredient, and an adhesive. Said transdermal therapeutic systems are characterized in that they are able to continuously adhere to the surface of the skin over a long period of time. During said long period of time, a) there is at least one time interval during which the TTS adhering to the surface of the skin is intensively exposed to water, and b) the active ingredient is transdermally released. The invention also relates to a method for the continuous transdermal release of at least one pharmaceutical active ingredient over a long period of time.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.